FairJourney Biologics introduces “THE ANTIBODY SERIES” conference

FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies, today announced the launch of the “THE ANTIBODY SERIES” – a 1-day conference bringing together top experts in the antibody field to explore the latest innovation within antibody drug discovery.